Printer Friendly
The Free Library
14,505,384 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Salix Pharmaceuticals to Present at Roth Capital Partners Conference.


RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:SLXP) today announced that the Company will present at the 19th Annual Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services,  Growth Stock Conference in Laguna Niguel, CA on Wednesday, February 21, 2007 at 2:00 p.m. ET.

Interested parties can access a live audio web cast of this presentation at http://www.salix.com. A replay of this presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina For other uses of this name, see Raleigh.
Raleigh (IPA: /ˈrɑli/, ral-ee) is the capital of the State of North Carolina and the county seat of Wake County.
, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's gastroenterology specialty sales and marketing team. Salix markets COLAZAL([R]), XIFAXAN([R]), OSMOPREP[TM], VISICOL([R]), MOVIPREP([R]), AZASAN([R]), ANUSOL-HC([R]) and PROCTOCORT([R]). Balsalazide tablets, Granulated gran·u·late  
v. gran·u·lat·ed, gran·u·lat·ing, gran·u·lates

v.tr.
1. To form into grains or granules.

2. To make rough and grainy.

v.intr.
 Mesalamine, SANVAR([R]) (600 ug vials vapreotide acetate powder) and Xifaxan for additional indications are under development.

Salix trades on the NASDAQ Global Market under the ticker symbol Ticker Symbol

An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors
 "SLXP".

For more information please contact the Company at 919-862-1000 or visit our web site at www.salix.com. Information on our web site is not incorporated in our SEC filings.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 14, 2007
Words:203
Previous Article:Salix Pharmaceuticals Announces 4Q2006 and FY2006 Financial Results Conference Call and Webcast.
Next Article:Ohio Gastroenterology Group Goes Live on athenahealth's On-Demand Practice Management Service.
Topics:



Related Articles
Capital event. (Wall Street West).(Roth Capital Partners investor conference)(Brief Article)
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.
Salix Pharmaceuticals to Present at Roth Capital Partners Conference.
Salix Pharmaceuticals to Present at Roth Capital Partners Conference.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.
Salix Pharmaceuticals to Present at Roth Capital Conference.
Salix Pharmaceuticals to Present at Four Investment Conferences During April.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference.
Salix Pharmaceuticals to Present at Wachovia Securities Healthcare Conference.
Salix Pharmaceuticals to Present at Three Investment Conferences During May and June.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles